Cell Therapy Market (Cell Type - Stem Cell, and Differentiated Cell; Therapy Type - Allogenic Therapies, and Autologous Therapies; Application - Autoimmune Diseases, Oncology, Dermatology, Muscoskeletal Therapies, and Other Applications; End-users - Hospitals and Clinics, Biotechnology and Pharmaceutical Companies, and Research Institutes): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025

  • Published : June, 2019

  • Rep Id : HC0568

  • Category : Healthcare & Medical Devices

  • Status : Published

A recent report published by Infinium Global Research on cell therapy market provides in-depth analysis of segments and sub-segments in the global as well as regional cell therapy market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional cell therapy market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global cell therapy market. According to the report, the global cell therapy market is projected to grow at a healthy CAGR over the forecast period of 2019-2025.

 

Market Insight

Cell therapy involves the treatment of diseases by injecting, grafting or implanting cellular material into the patient’s body. Cell therapy is used to treat various medical conditions, in different organs and operates through several modes of delivery. The mechanism of action of cell therapy varies from disease to disease, however, there are two major principles by which cells assist therapeutic action. This mechanism involves either stem cell engraftment, differentiation & long term replacement of damaged tissue or cells releasing soluble factors such as cytokines, chemokines, and growth factors that facilitate self-healing. Compared to conventional drug therapy, cell therapy experience less immune rejection and the cells involved in therapy are easily available. Cell therapy is used to treat ailments including various types of cancers, cardiac disorders, degenerative neurological and neuromuscular diseases and immunological disorders.

 

Increasing incidences of cancer across the globe is the primary growth factor of the cell therapy market. Factors such as the growing aging patient population, the rise in cell therapy transplantations globally, and rising awareness about diseases are driving the growth of the cell therapy market. Rising funding from the government to support cell therapy clinical trials and the introduction of effective guidelines for cell therapy manufacturing is also driving the growth of the market. Additionally, decreasing prices of stem cell therapies are leading to increased preference of buyers towards cell therapy. Development of cell banking services and subsequent expansion of production, storage, and characterization of cells are improving volumetric capabilities of the cell therapy market at a global level. However, the high cost of transplantation treatment and stringent regulatory policies hampers the growth of the cell therapy market. Automation in cell therapy manufacturing providing intensive opportunities in the market.

 

North America holds a prominent share in the global cell therapy market. The prevalence of cancer and blood-related disorders coupled with high investments in the research and development of novel technologies contributes to the growth of the cell therapy market in the North America region. According to the National Cancer Institute, in 2018, approximately 1,735,350 new cases of cancer diagnosed in the United States. Furthermore, North America has a well-established healthcare infrastructure that acts as an added advantage for the growth of the cell therapy market in this region. Asia-Pacific region is anticipated to stimulate the growth of the cell therapy market. The rising awareness about advanced medicinal therapies in the Asia-Pacific region contributes to the increasing demand for cell therapy in the Asia-Pacific region.


Global Cell Therapy Market

 

Segment Covered

The report on global cell therapy market covers segments such as cell type, therapy type, application, and end-users. On the basis of cell type, the sub-markets include stem cell, and differentiated cell. On the basis of therapy type, the sub-markets include allogenic therapies, and autologous therapies. On the basis of application, the sub-markets include autoimmune diseases, oncology, dermatology, muscoskeletal therapies, and other applications. On the basis of end-users, the sub-markets include hospitals and clinics, biotechnology and pharmaceutical companies, and research institutes.

 

Companies Profiled:

The report provides profiles of the companies in the market such as NuVasive, Inc, Kolon TissueGene, Inc., JCR Pharmaceuticals Co., Ltd., Osiris Therapeutics, Inc., Stemedica Cell Technologies, Inc., MEDIPOST, Celgene Corporation, ANTEROGEN.CO., LTD, and Vericel Corporation.

 

Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of cell therapy market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.


Other Reports in This Category
24 hour delivery through email
9923950043 Monday to Frieday 9am-7pm
looking for discount